Showing results (931-940 of 1,020) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|November 16, 2022
SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progressionMariafausta Fischietti, Frank Eckerdt, Ricardo E Perez, et al.Cancer Research Communications|January 30, 2023
Prospective associations of hemoglobin A1c and c-peptide with risk of diabetes-related cancers in the Cancer Prevention Study-II Nutrition CohortPeter T Campbell, Christina C Newton, Eric J Jacobs, et al.Cancer Research Communications|February 6, 2026
A classifier for patient-derived colorectal tumoroid drug sensitivity using confocal imaging and growth rate inhibition metricsBaard Cristoffer Sakshaug, Tonje H Haukaas, Evelina Folkesson, et al.Cancer Research Communications|February 2, 2026
CLDN6 Expression Plasticity in Ovarian Cancer: Insights into Therapeutic Optimization for CLDN6-Targeted ImmunotherapyNaoki Kimura, Kenji Taniguchi, Shinichi Onishi, et al.Cancer Research Communications|March 21, 2025
23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa ActivationJoel S Benjamin, Abigail Jarret, Shashank Bharill, et al.Cancer Research Communications|April 30, 2025
Glecirasib, a Potent and Selective Covalent KRAS G12C Inhibitor Exhibiting Synergism with Cetuximab or SHP2 Inhibitor JAB-3312Peng Wang, Xin Sun, Xueting He, et al.Cancer Research Communications|March 12, 2026
Predominant Merkel Cell Polyomavirus DNA Detection in Essential Thrombocythemia within Myeloproliferative NeoplasmsDan Liu, Sixuan J Wang, Amanda Macamo, et al.Cancer Research Communications|March 16, 2026
Characterization of mitochondrial double-stranded RNA levels in Non-Small Cell Lung CarcinomaMatthew R Krieger, Sandy Che-Eun S Lee, Ting Fu, et al.Cancer Research Communications|February 22, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid TumorsJong Chul Park, David Berz, Manish R Sharma, et al.Cancer Research Communications|February 26, 2026
Mutant Isocitrate dehydrogenase 1 sensitizes intrahepatic cholangiocarcinoma cells to MDM2 inhibitorsChien-Tsung Liu, Yung-Yeh Su, Nai-Jung Chiang, et al.Pageof 102